ARCHIVES

In Brief: NIH gives Advisors $50 Raise, Effective April 1, No Fooling

This article is from The Cancer Letter archive.

Vol. 25 No. 10 | March 12, 1999

Download PDF Visit The Full Archive

Related Articles

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009

Pathology In Operating Suite Cuts Need for More Surgery

February 24, 2012

Amgen Claimed QOL Benefit Despite FDA Label Change.

May 18, 2007

Funding Opportunities: ACS Calif. Division Calls for Applications

August 1, 1997

Northwestern Repays Government $3 Million To Settle Claims Over Use Of NCI Grants; Researcher Bennett Now Faces Feds Alone

August 9, 2013

New Model For Risk Assessment Includes Alcohol, Exercise, Weight

July 29, 2011